1Y Target$404.06Near-term target
5Y Target$565.87Compound horizon
10Y Target$831.80Long-dated conviction
FCF$389mTTM · 03/26CFCF $389m — modest; watch for margin expansion · TTM computed from 4 most-recent quarters (TTM · 03/26).
Rev+21.6%TTM YoYA-Revenue +21.6% — strong growth, well above S&P median (~7%) · TTM YoY from trailing-4-quarter revenue sum vs prior 4 quarters.
D/E0.23totalA-D/E 0.23 — conservative leverage, strong balance sheet · Total D/E computed from balance sheet (short-term + long-term debt + lease obligations) ÷ stockholders equity. More accurate than native field, which often uses long-term debt only.
P/E39.4xCP/E 39.4 — rich valuation; execution risk material
PEG1.83proxyC+PEG 1.83 — modest premium; above fair value · PEG proxy: P/E ÷ revenue growth % (true PEG requires forward EPS estimates, not in Finnhub free tier).
Why now
Aerospace & Defense · market cap $20.5b. 14% off the 52-week high of $407.00. Revenue growing +22%, comfortably above the S&P median.
Moat
Net margin 13% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 20% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately.
Risk
Trailing P/E 39x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
Horizon
1-3 yr $404.06 (structural (no analyst coverage)) — fundamentals + valuation re-rating. 5 yr $565.87 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $831.80 if current growth sustains into durable earnings power.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See
terms and
methodology for full disclosures.